FDA.reportPublic FDA data

NDC 70518-2725-01 - Naloxone Hydrochloride

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
70518-2725
Requested NDC
70518-2725-01
Package NDCs from labels
70518-2725-1, 70518-2725-0, 70518-2725-01
Manufacturer
REMEDYREPACK INC.
Effective date
2026-02-10
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Naloxone Hydrochloride - REMEDYREPACK INC.REMEDYREPACK INC.2026-02-10HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70518-2725-0Naloxone Hydrochloride10 in 1 BOXINJECTION108
70518-2725-1Naloxone Hydrochloride2 mL in 1 SYRINGEINJECTION28

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
70518-2725NALOXONE HYDROCHLORIDE INJECTION [REMEDYREPACK INC.]6Current NDC, Legacy NDC, 2 package rows20250402_68df290c-d776-4cfc-9565-332eb56c4723.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 4 of 5 · 100 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Naloxone HydrochlorideNALOXONE HYDROCHLORIDEPar Health USA, LLC3ae08e26-223b-4971-b2f1-f1e183a3f9302024-04-11Warnings, Adverse reactionsExact identifier
rxcui: 1191250
unii: F850569PQR
Naloxone HydrochlorideNALXONE HYDROCHLORIDEHikma Pharmaceuticals USA Inc.1bef59b9-7d51-4f19-a054-44b8eb6c63982024-04-10Warnings, Adverse reactionsExact identifier
unii: F850569PQR
naloxone hydrochlorideNALOXONE HYDROCHLORIDELifestar Pharma LLCef647e2a-84e7-4e3e-942a-b6fc250141b62024-03-04Warnings, Adverse reactionsExact identifier
unii: F850569PQR
NALOXONE HYDROCHLORIDENALOXONE HYDROCHLORIDEHF Acquisition Co LLC, DBA HealthFirstc72a60fb-196d-3f02-e053-2995a90ad9062024-02-22Warnings, Adverse reactionsExact identifier
rxcui: 1191250
unii: F850569PQR
Narcan Naloxone HCLNARCAN NALOXONE HCLHF Acquisition Co LLC, DBA HealthFirst11d770b8-b768-ba3d-e063-6394a90a61a62024-02-20WarningsExact identifier
unii: F850569PQR
NALOXONE HYDROCHLORIDENALOXONE HYDROCHLORIDEHF Acquisition Co LLC, DBA HealthFirst94ff1857-06da-7986-e053-2a95a90afb182024-02-19Warnings, Adverse reactionsExact identifier
unii: F850569PQR
NALOXONE HYDROCHLORIDENALOXONE HYDROCHLORIDEHF Acquisition Co LLC, DBA HealthFirstc90e2d85-ed94-2c00-e053-2a95a90ad2a02024-01-30Warnings, Adverse reactionsExact identifier
unii: F850569PQR
Naloxone HydrochlorideNALOXONE HYDROCHLORIDEActavis Pharma, Inc.49350f7e-d613-40a8-8941-a2ec30eafdf32024-01-30WarningsExact identifier
unii: F850569PQR
NALOXONE HClNALOXONE HCLHF Acquisition Co LLC, DBA HealthFirstf8fcda15-8ba6-e66a-e053-6294a90a385c2024-01-28Warnings, Adverse reactionsExact identifier
unii: F850569PQR
NALOXONE HCINALOXONE HCIHF Acquisition Co. LLC, DBA Health First73c1bad3-6ac3-8682-e053-2a91aa0a176a2024-01-27Warnings, Adverse reactionsExact identifier
unii: F850569PQR
NALOXONE HYDROCHLORIDENALOXONE HYDROCHLORIDEHF Acquisition Co LLC, DBA HealthFirste65e03c1-9a66-b30b-e053-2995a90aeb732024-01-27Warnings, Adverse reactionsExact identifier
rxcui: 1191250
unii: F850569PQR
NALOXONE HYDROCHLORIDENALOXONE HYDROCHLORIDEHF Acquisition Co. LLC, DBA HealthFirst74fc593e-ed47-efae-e053-2991aa0a59972024-01-25Warnings, Adverse reactionsExact identifier
application number: ANDA072076
rxcui: 1191250
unii: F850569PQR
Naloxone HydrochlorideNALOXONE HYDROCHLORIDETeva Pharmaceuticals, Inc.3a73ee4b-c2a4-496f-be90-9f78c80460622024-01-01WarningsExact identifier
unii: F850569PQR
NALOXONE HYDROCHLORIDENALOXONE HYDROCHLORIDEA-S Medication Solutions46f27d04-d4d2-4ef1-9cc5-4d58f4056f062023-12-27WarningsExact identifier
unii: F850569PQR
Naloxone HydrochlorideNALOXONE HYDROCHLORIDESomerset Therapeutics, LLCb59ee3cc-9604-4abc-81be-897e2f42aa672023-12-19Warnings, Adverse reactionsExact identifier
unii: F850569PQR
Naloxone HydrochlorideNALOXONE HYDROCHLORIDE NASALA-S Medication Solutions4517afa1-4b17-4a15-b91b-65b18bd0558f2023-11-24Warnings, Adverse reactionsExact identifier
unii: F850569PQR
NARCAN NALOXONE HCINARCAN NALOXONE HCIHF Acquisition Co LLC, DBA HealthFirst784a0e98-c2d6-f845-e053-2991aa0ac4b42023-10-10Warnings, Adverse reactionsExact identifier
unii: F850569PQR
NALOXONE HYDROCHLORIDENALOXONE HYDROCHLORIDEA-S Medication Solutions0b3b5214-6f91-4bba-82d6-d57b16845df52023-10-01Warnings, Adverse reactionsExact identifier
unii: F850569PQR
NARCANNALOXONE HYDROCHLORIDEA-S Medication Solutions139c30b9-5600-48f5-8610-0cacd27823982023-09-28Warnings, Adverse reactionsExact identifier
unii: F850569PQR
Naloxone HydrochlorideNALOXONE HYDROCHLORIDEHospira, Inc.b598c237-032d-4bb5-0e92-50eabd863dac2023-06-04Warnings, Adverse reactionsExact identifier
unii: F850569PQR

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.